Literature DB >> 3123249

Natural killer cell activity during cortisol and adrenaline infusion in healthy volunteers.

E Tønnesen1, N J Christensen, M M Brinkløv.   

Abstract

The effects of cortisol and adrenaline on natural killer (NK) cell activity and the distribution of circulating lymphocyte subpopulations were studied in twenty volunteers, using a continuous intravenous infusion pattern to simulate some of the hormonal changes induced by major surgery. The participants were allocated to receive either cortisol for 5 h, adrenaline for 1 h, cortisol for 5 h with simultaneous adrenaline during the last hour, or placebo for 5 h. Cortisol induced leucocytosis, neutrophilia, and lymphopenia with marked reduction in the number of T-lymphocyte subsets (OKT3+, OKT4+, and OKT8+ cells). No changes were induced in the activity or number of NK (Leu 11+) cells. Adrenaline produced an instantaneous increase in NK-cell activity accompanied by a selective increase in circulating NK cells. Significant leucocytosis, lymphocytosis and neutrophilia occurred. All measurements returned to preinfusion levels within 15 min after completing infusion. The effects of simultaneous infusion of cortisol and adrenaline were equal to the additive response to the hormones administered separately, except for the leucocytosis, which clearly exceeded this. In the placebo group all measurements remained unchanged. The results confirm the role of adrenaline as a potent stimulator/inducer of NK-cell activity. Adrenaline may be responsible for the increase in NK-cell activity during anaesthesia and major surgery.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3123249     DOI: 10.1111/j.1365-2362.1987.tb01148.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  23 in total

1.  Acute stress reduces intraparenchymal lung natural killer cells via beta-adrenergic stimulation.

Authors:  O Kanemi; X Zhang; Y Sakamoto; M Ebina; R Nagatomi
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

2.  A study for prevention of chronic fatigue Part 1. Effects of endurance running during one month on blood properties and subjective fatigue.

Authors:  T Kumae; T Kawahara; I Uchiyama
Journal:  Environ Health Prev Med       Date:  1997-04       Impact factor: 3.674

3.  The effects of incremental submaximal exercise on circulating leukocytes in physically active and sedentary males and females.

Authors:  N M Moyna; G R Acker; K M Weber; J R Fulton; F L Goss; R J Robertson; B S Rabin
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

4.  Impact of heat exposure and moderate, intermittent exercise on cytolytic cells.

Authors:  I K Brenner; Y D Severs; P N Shek; R J Shephard
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

Review 5.  Adhesion molecules, catecholamines and leucocyte redistribution during and following exercise.

Authors:  Roy J Shephard
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 6.  Exercising in environmental extremes : a greater threat to immune function?

Authors:  Neil P Walsh; Martin Whitham
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

7.  Circulating T cell subtypes in polymyalgia rheumatica and giant cell arteritis: variation in the percentage of CD8+ cells with prednisolone treatment.

Authors:  G D Pountain; M T Keogan; D L Brown; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1993-10       Impact factor: 19.103

8.  Changes of natural killer cells during acute psychological stress.

Authors:  M Schedlowski; R Jacobs; G Stratmann; S Richter; A Hädicke; U Tewes; T O Wagner; R E Schmidt
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

9.  Leukocytosis after fluid loading and induction of epidural anesthesia.

Authors:  Dan Drobin; Robert G Hahn
Journal:  J Anesth       Date:  1995-09       Impact factor: 2.078

Review 10.  Exercise and the immune system. Natural killer cells, interleukins and related responses.

Authors:  R J Shephard; S Rhind; P N Shek
Journal:  Sports Med       Date:  1994-11       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.